Global Proteomics Market 2022 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2030

SDKI Inc. published a new report on the Global Proteomics Market-Forecast 2022-2030

This study includes the statistical and analytical approaches needed to grow the proteomics market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111616

The proteomic market is estimated to grow from a market value of US $ 22.37 billion in 2022 to US $ 58.43 billion by 2030, with a CAGR of 14.7% during the 2022-2030 forecast period.

Proteomics is based on basic technical foundations such as peptide mixtures, fractionated complex proteins, and mass spectrometry (MS). , Identify individual proteins. Most proteomics discoveries have been directed to cancer research, as well as drug and biomarker research. At the cellular level, proteomics is about which proteins are expressed, when and where they are expressed, their structure in both active and inactive states, what role they play in the life of the cell, and others. It covers topics such as how to interact with proteins and molecules in.

Sample URL for the report
https://www.sdki.jp/sample-request-111616

Increased demand for pharmaceuticals is expected to drive growth in the proteomics market during the forecast period. Technological advances and increasing demand for personalized medicine are major drivers of growth in the global proteomics market. According to the Personalized Medicine Union, the report shows that the number of personalized medicines on the market in the United States has increased from 132 in 2016 to 286 in 2020. In addition, increased R & D spending by pharmaceutical and biotechnology companies, increased government funding, and technological advances are expected to drive growth in the proteomics market. However, the high cost of equipment can curb the growth of the proteomics market during the forecast period.

Global market growth can be attributed to various significant advances in the healthcare industry to promote health through the development of three basic parameters: detection, prevention, and treatment. These parameters are needed to measure health, quality of life, and the overall health system. In addition, rising medical costs are driving market growth. According to the Organization for Economic Co-operation and Development (OECD) statistics, Japan's total per capita health care costs (government, compulsory health insurance, voluntary health insurance) increased from US $ 4297.13 in 2016 to US $ 4823 in 2019. Similarly, in the United States, it increased from $ 9880.16 to $ 11072 in 2019. Germany has witnessed an increase from $ 5668 to $ 6646, and the United Kingdom has observed growth from $ 3990 to $ 4653.05 during the above period. Globally, healthcare costs are projected to grow at a CAGR of approximately 5% between 2020 and 2024.

Advances in the healthcare sector are estimated to provide lucrative business opportunities for key players to take advantage of these opportunities in the coming years. In addition, there are several initiatives taken by healthcare professionals and government agencies to overcome some challenges (unreachable and affordable medical services, lack of investment in health care, trained doctors and nurses, etc.). It is expected to boost market growth during the forecast period.

Proteomics market segment

The proteomics market is divided by product and service type (device technology, software services and reagents), application type (clinical diagnosis, drug discovery, and other applications), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

The proteomics market The proteomics market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

Details of the research report
https://www.sdki.jp/reports/proteomic-market/111616

The North American region dominates the market and is expected to lead the market during the forecast period. This is due to its innovative next-generation therapies and extensive research. Increased investment in the development of structure-based drug designs, increased research in the field of omics, and increased demand for high-quality research tools for data reproducibility will also increase the market in the region during the forecast period. Is boosting the growth of. Meanwhile, the Asia Pacific proteomics market is expected to grow during the forecast period. This is primarily due to increased awareness of personalized treatments and increased investment by the government and private sector.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.